← Return to Brinsupri (aka Brensocatib)

Discussion
scoop avatar

Brinsupri (aka Brensocatib)

MAC & Bronchiectasis | Last Active: May 28 3:28pm | Replies (169)

Comment receiving replies
Profile picture for Sue, Volunteer Mentor @sueinmn

@lvnl Here is a different viewpoint to consider.

Insurers and Medicare need to control costs when and where possible to avoid more premium increases. I know many people insurance companies believe are rich and can afford everything, but when I think about what my medical care and prescriptions cost, the $10,000 I pay in premiums and the $10,000 or so my employer contributes don't begin to cover the costs of my husband's & my care, even with the discounts the pharmacy benefit managers negotiate, and the limits Medicare places on charges.

Whenever there are generic or bio-equvalent drugs available we willingly try them. Nearly all have been fine and have saved both me and the company money. If they do not work after a reasonable trial, Blue Cross has made exceptions after sufficient documentation.

Similarly, when I wanted a faster nebulizer for my convenience, I didn't expect my insurance company to cover it. But, if I NEED it to dispense a specific drug, I'll fight for it.

Expensive specialty drugs like Brinsupri will need to demonstrate to insurers that they reduce primary medical expenses (like hospitalizations) in order to get onto their formularies or continue be covered.

Jump to this post


Replies to "@lvnl Here is a different viewpoint to consider. Insurers and Medicare need to control costs when..."

@sueinmn Would there be consideration for prevention - for the long term advantages of a drug like Brinsupri that reduces inflammation for those with worsening or more severe BE disease, and would presumably reduce risk of hospitalization or more urgent intensive care and other costly antibiotics for patients in the future?

Drug costs are high. It’s a bit shocking to hear the cost of a drug plan in the United States though, relative to other westernized countries.

@sueinmn Thanks for spelling that out! I can get that that's how it works. I didn't mean to imply I object to switching to the biosimilar replacement for Humira. It's been well established as just as safe and effective. The cost of Humira is $77,000 annually in the U.S. and far less everywhere else in the world. That's the insane part.